Dorota Goplen

Bergen, 5021, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.

Journal: Redox biology
Published: May 13, 2026

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Journal: Clinical and translational radiation oncology
Published: May 03, 2026

Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series.

Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series.

Journal: Frontiers in surgery
Published: April 22, 2026

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Journal: Clinical and translational radiation oncology
Published: December 09, 2025

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

Journal: NPJ precision oncology
Published: October 14, 2025

Germline variants in patients diagnosed with pediatric soft tissue sarcoma.

Germline variants in patients diagnosed with pediatric soft tissue sarcoma.

Journal: Acta oncologica (Stockholm, Sweden)
Published: May 06, 2024

Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Journal: British journal of cancer
Published: February 21, 2024

Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines.

Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: July 03, 2023

Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI.

Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI.

Journal: Neuro-oncology advances
Published: May 08, 2023

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Journal: BMJ open
Published: March 20, 2023

Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.

Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.

Journal: PloS one
Published: August 26, 2022

Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway.

Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway.

Journal: Frontiers in cell and developmental biology
Published: August 18, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026